Loading…eh

🔆 📖 👤

Statutory Instruments

2023 No. 239

National Health Service, England And Wales

National Health Service, Scotland

Health And Personal Social Services, Northern Ireland

The Branded Health Service Medicines (Costs) (Amendment) Regulations 2023

Made

28th February 2023

Laid before Parliament

2nd March 2023

Coming into force

1st April 2023

The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 263(1), 264(3), 266(1) and (4A) and 272(7) and (8) of the National Health Service Act 2006( 1 ).

The Secretary of State has consulted in accordance with section 263(1) and (1A) of that Act.

Citation, commencement and extent

1. —(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 and come into force on 1st April 2023.

(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.

Amendment of regulation 3 of the Branded Health Service Medicines (Costs) Regulations 2018

2. —(1) Regulation 3 (Payment scheme) of The Branded Health Service Medicines (Costs) Regulations 2018( 2 ) is amended as follows.

(2) In paragraph (1), for the table substitute—

Table

Applicable Period Payment Percentage
1st April 2023 to the end of 2023 27.5%
2024 and any subsequent calendar year 27.5% .

(3) In paragraph (1B)—

(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023” ,

(b) for “17.7%” substitute “28.6%” , and

(c) for “14.3%” substitute “27.5%” .

(4) In paragraph (1C)—

(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023” ,

(b) in sub-paragraph (a)—

(i) for “1st January 2022” substitute “1st January 2023” , and

(ii) for “30th June 2022” substitute “31st March 2023” , and

(c) in sub-paragraph (b), for “10.9%” substitute “24.4%” .

Signed by the authority of the Secretary of State for Health and Social Care

Will Quince

Minister of State,

Department of Health and Social Care

28th February 2023

( 1 )

2006 c. 41 ; section 263 was amended by the Health Service Medical Supplies (Costs) Act (c. 23) (“ the 2017 Act ”), section 5 and 10(5). Section 266 was amended by the 2017 Act, section 6(5) to (9) and 7(6). See section 275(1) of the National Health Service Act 2006 for definition of “regulations” that are relevant to the powers being exercised.

( 2 )

S.I 2018/345 ; relevant amending instruments are S.I. 2018/1255 , S.I. 2020/258 and S.I. 2022/593 .

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
The Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 (2023/239)
Version from: original only

Displaying information

Status of this instrument

in force Provision is in force
in force* In force only for specified purposes (see footnote)
not in force Not in force in England (may be in force in other geographies, see footnotes)
defined term Defined term
dfn Defined term (alternative style)
footnote commentary transitional and savings in force status related provisions geo extent insert/omit source count in force adj
Defined Term Section/Article ID Scope of Application

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.

Contains public sector information licensed under the Open Government Licence v3.0.